VDAC2 and nasopharyngeal carcinoma: reported that in nasopharyngeal carcinoma tumor models, as a substrate of E3 ubiquitin ligase-TRIM21, VDAC2 is degraded by TRIM21 via ubiquitination of K48 ligand, thereby inhibiting type-I interferon responses (34).